Ketamine and Spravato Treatment in Tennessee

Based on published pricing and coverage rules as of 2019-03-05. Sources for every figure this tool can show:

Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)

Under Original Medicare Part B in 2026 you pay a $283 yearly deductible first, and after that you generally pay 20% of the Medicare-approved amount for covered services. as of 1 Jan 2026 · Centers for Medicare and Medicaid Services (source 2, opens in a new tab)Deductible and premium amounts are set annually and change each January.

The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 3, opens in a new tab)

Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 6, opens in a new tab)

Best available information: Spravato's list price is not published by the manufacturer or in any free public source. At launch in 2019 the wholesale acquisition cost was around $590 for a 56 mg dose and $885 for an 84 mg dose, and the current list price is very likely higher. as of 5 Mar 2019 · Drugs.com (source 7, opens in a new tab)Wholesale acquisition cost is published only in paywalled pricing compendia. The figures here are seven years old and come from a secondary source, so we do not use them to produce a dollar estimate — the estimator suppresses Spravato cash figures rather than presenting a number this weak.

Spravato does not appear on TennCare's preferred drug list or its clinical criteria at all. That is not the same as TennCare refusing to cover it: TennCare routes medicines that a provider administers to the medical benefit, where your own managed care organisation decides coverage rather than the pharmacy list. The practical answer is to ask your TennCare plan, not your pharmacy. as of 15 Jul 2026 · State of Tennessee, Division of TennCare (source 8, opens in a new tab)We confirmed the absence by searching the full text of both TennCare documents. The conclusion that coverage sits with the managed care organisation follows from the preferred drug list's own stated rule for provider-administered medicines.

Best available information: Few Tennessee clinics publish a price for intramuscular ketamine. One Nashville practice lists $225 for the injection; across the state a band of roughly $200 to $450 a session is plausible but largely inferred. as of 18 Jul 2026 · Nashville Psychedelic Center (source 10, opens in a new tab)One published Tennessee price supports the low end of this band. The rest is inference, so treat the range as wide on purpose.

Cash-pay IV ketamine infusions for depression in Tennessee typically run about $350 to $600 for a standard forty-to-sixty minute session. Longer infusions used for chronic pain are priced separately and cost considerably more. as of 18 Jul 2026 · Published Tennessee clinic price lists (source 11, opens in a new tab)The clinic sets the price. Treat this as a guide to what a reasonable answer sounds like, not as a quote.

Best available information: No Tennessee clinic we checked publishes a price for sublingual or lozenge ketamine. Nationally, at-home telehealth programmes advertise from roughly $165 to $430 a session, but we have no Tennessee figure. as of 5 May 2026 · HealingMaps (source 12, opens in a new tab)This is a national figure from a secondary directory, not a Tennessee price. Ask separately what the medicine costs and what the supervised session costs — they are billed differently.

Best available information: Tennessee clinics effectively do not publish self-pay Spravato prices. Those offering it bill the medicine through insurance or list only a monitoring fee, so a self-pay patient has to ask for an individual quote. as of 18 Jul 2026 · Published Tennessee clinic pricing pages (source 13, opens in a new tab)Our estimator does not produce a self-pay Spravato figure, because there is no Tennessee evidence strong enough to build one on.

The Spravato withMe savings programme is not available to anyone using a state or federal government health programme, including Medicare, Medicaid, TRICARE, the Department of Defense, and the Veterans Administration. as of 18 Jul 2026 · Johnson & Johnson (source 16, opens in a new tab)

Through the Spravato withMe savings programme, eligible patients with commercial insurance may pay as little as $10 per treatment for the medicine itself, subject to yearly maximum benefits and quantity limits. as of 18 Jul 2026 · Johnson & Johnson (source 17, opens in a new tab)The programme covers the medicine, not the office visit or the two-hour observation, which is often the larger share of the bill. The official terms state that a yearly maximum applies but do not publish the amount, so we do not either. Terms are set per calendar year.